Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 7

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 7
---
con Inc. offers the broadest portfolio of products to enhance sight and improve people’s lives. Alcon Inc.’s surgical and vision care products touch the lives of more than 260 million people in over
140 countries each year living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors.

Rascasse Merger Sub, Inc.

Merger Sub is a Delaware corporation and a wholly owned subsidiary of Alcon. Merger Sub was incorporated on July 28, 2025 and
has not engaged in any business activities other than in connection with the transactions contemplated by the Merger Agreement.

The
principal executive offices of Merger Sub are located at 6201 South Freeway, Fort Worth, Texas 76134, and its telephone number is (817) 293-0450.

The Merger

On
the terms and subject to the conditions set forth in the Merger Agreement, and in accordance with the General Corporation Law of the State of Delaware (which this proxy statement refers to as the “DGCL”), at the Effective Time (as
defined below), Merger Sub will merge with and into STAAR, as a result of which the separate corporate existence of Merger Sub will cease and STAAR will be the surviving company of the Merger (which this proxy statement refers to as the
“Surviving Corporation”). As a result of the Merger, STAAR will become a wholly owned subsidiary of Alcon, and STAAR common stock will no longer be publicly traded and will be delisted from NASDAQ.

In addition, following the Merger, it is expected that STAAR common stock will be deregistered under the Securities Exchange Act of 1934, as
amended (which this proxy statement refers to as the “Exchange Act”), and STAAR will no longer file periodic or other reports with the U.S. Securities and Exchange Commission (which this proxy statement refers to as the
“SEC”). If the Merger is consummated, holders of STAAR common stock will not own any shares of the capital stock of the Surviving Corporation. The Merger will become effective at such time as the certificate of merger meeting the
requirements of Section 251 of the DGCL relating to the Merger has been duly filed with the Secretary of State of the State of Delaware in accordance with the DGCL, or at such later time as may be agreed by the parties and specified in the
certificate of merger in accordance with the DGCL (which this proxy